{
  "openalex_id": "W2792871305",
  "doi": "https://doi.org/10.7326/acpjc-2018-168-4-023",
  "title": "In patients with rheumatoid arthritis, bDMARD therapy was not associated with malignant neoplasms",
  "abstract": "Source Citation Wadstr√∂m H, Frisell T, Askling J; Anti-Rheumatic Therapy in Sweden Study Group. Malignant neoplasms in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors, tocilizumab, abatacept, or rituximab in clinical practice: a nationwide cohort study from Sweden. JAMA Intern Med. 2017;177:1605-12. 28975211",
  "authors": [
    {
      "display_name": "Anne Holbrook",
      "id": "A5028992865",
      "orcid": "https://orcid.org/0000-0002-3371-4187",
      "institutions": [
        {
          "id": "I98251732",
          "display_name": "McMaster University",
          "country_code": "CA",
          "type": "funder"
        }
      ],
      "is_corresponding": true,
      "raw_author_name": "Anne Holbrook"
    }
  ],
  "publication_year": 2018,
  "publication_date": "2018-02-19",
  "type": "letter",
  "cited_by_count": 1,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S119722071",
    "display_name": "Annals of Internal Medicine",
    "issn_l": "0003-4819",
    "issn": [
      "0003-4819",
      "1539-3704"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310316812"
  },
  "volume": "168",
  "issue": "4",
  "first_page": "JC23",
  "last_page": "JC23",
  "open_access": {
    "is_oa": false,
    "oa_status": "closed",
    "oa_url": null,
    "any_repository_has_fulltext": false
  },
  "concepts": [
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.98040855
    },
    {
      "id": "C2779605438",
      "display_name": "Abatacept",
      "level": 4,
      "score": 0.87776124
    },
    {
      "id": "C2777575956",
      "display_name": "Rheumatoid arthritis",
      "level": 2,
      "score": 0.84375453
    },
    {
      "id": "C2780653079",
      "display_name": "Rituximab",
      "level": 3,
      "score": 0.74418676
    },
    {
      "id": "C2777178219",
      "display_name": "Tocilizumab",
      "level": 3,
      "score": 0.70097995
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.6330805
    },
    {
      "id": "C143998085",
      "display_name": "Oncology",
      "level": 1,
      "score": 0.48611712
    },
    {
      "id": "C2909063479",
      "display_name": "Antirheumatic Agents",
      "level": 3,
      "score": 0.46668774
    },
    {
      "id": "C1862650",
      "display_name": "Physical therapy",
      "level": 1,
      "score": 0.33673584
    },
    {
      "id": "C2779338263",
      "display_name": "Lymphoma",
      "level": 2,
      "score": 0.2573728
    }
  ],
  "topics": [
    {
      "id": "T10200",
      "display_name": "Rheumatoid Arthritis Research and Therapies",
      "score": 0.9969
    },
    {
      "id": "T11157",
      "display_name": "Chronic Lymphocytic Leukemia Research",
      "score": 0.991
    },
    {
      "id": "T10755",
      "display_name": "HER2/EGFR in Cancer Research",
      "score": 0.9902
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.7326/acpjc-2018-168-4-023",
  "pdf_url": null,
  "retrieved_date": "2025-07-30T14:45:51.096028",
  "source_database": "OpenAlex"
}